XORTX Therapeutics (XRTX) Prepaid Assets (2020 - 2026)
XORTX Therapeutics' (XRTX) quarterly Prepaid Assets came in at $56138.0 in Q1 2026, down 70.6% YoY from $190949.0 in Q1 2025, and up 148.3% on a QoQ basis from $22609.0 in Q4 2025.
XORTX Therapeutics (XRTX) Prepaid Assets (2020 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 7 years of Prepaid Assets data on file, last reported at $56138.0 in Q1 2026.
- Quarterly Prepaid Assets fell 70.6% year-over-year to $56138.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56138.0 (down 70.6% YoY) and the FY2025 annual result came in at $22609.0, down 87.81% from the prior year.
- Prepaid Assets advanced to $56138.0 in Q1 2026, from $22609.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $722716.6 in Q1 2022 to a low of $22609.0 in Q4 2025.
- A 5-year average of $219851.8 and a median of $185412.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 143.6% — and 2025, when it sank 87.81%.
- Tracing XRTX's Prepaid Assets over 5 years: stood at $378783.2 in 2022, then plunged by 37.44% to $236966.0 in 2023, then decreased by 21.76% to $185412.0 in 2024, then slumped by 87.81% to $22609.0 in 2025, then jumped by 148.3% to $56138.0 in 2026.
- The last three Prepaid Assets figures came in at $56138.0 (Q1 2026), $22609.0 (Q4 2025), and $30444.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,138.00 |
| Dec 31, 2025 | 22,609.00 |
| Sep 30, 2025 | 30,444.00 |
| Jun 30, 2025 | 97,589.00 |
| Mar 31, 2025 | 190,949.00 |
| Dec 31, 2024 | 185,412.00 |
| Sep 30, 2024 | 96,536.00 |
| Jun 30, 2024 | 207,290.00 |
| Mar 31, 2024 | 639,034.00 |
| Dec 31, 2023 | 236,966.00 |
| Sep 30, 2023 | 88,927.00 |
| Jun 30, 2023 | 183,667.00 |
| Mar 31, 2023 | 262,325.00 |
| Dec 31, 2022 | 378,783.18 |
| Sep 30, 2022 | 68,475.04 |
| Jun 30, 2022 | 269,619.45 |
| Mar 31, 2022 | 722,716.57 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 113,928.62 |
| Dec 31, 2020 | 202,655.08 |